Terns Pharmaceuticals Inc
NASDAQ:TERN

Watchlist Manager
Terns Pharmaceuticals Inc Logo
Terns Pharmaceuticals Inc
NASDAQ:TERN
Watchlist
Price: 6.515 USD -3.91%
Market Cap: 549.9m USD
Have any thoughts about
Terns Pharmaceuticals Inc?
Write Note

Relative Value

There is not enough data to reliably calculate the relative value of TERN.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TERN Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.6
vs History
vs Industry
Median 3Y
-6.7
Median 5Y
-7.1
Industry
23
Forward
-5.2
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-9.2
Industry
17.8
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-9.2
Industry
25.4
vs History
46
vs Industry
35
Median 3Y
2.7
Median 5Y
2.7
Industry
2.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.4
vs History
vs Industry
56
Median 3Y
-3.5
Median 5Y
-4.1
Industry
13.7
Forward
-3.1
vs History
vs Industry
52
Median 3Y
-3.5
Median 5Y
-4
Industry
17.2
Forward
-3.2
vs History
vs Industry
53
Median 3Y
-5.3
Median 5Y
-5.8
Industry
16.5
vs History
vs Industry
39
Median 3Y
-5.2
Median 5Y
-5.8
Industry
19.3
vs History
42
vs Industry
1
Median 3Y
96.8
Median 5Y
96.8
Industry
2

Multiples Across Competitors

TERN Competitors Multiples
Terns Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Terns Pharmaceuticals Inc
NASDAQ:TERN
572.2m USD 0 -5.7 -3.2 -3.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
368.4B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
US
Terns Pharmaceuticals Inc
NASDAQ:TERN
Average P/E: 33.4
Negative Multiple: -5.7
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top